| Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study A Rolfs, T Böttcher, M Zschiesche, P Morris, B Winchester, P Bauer, ... The Lancet 366 (9499), 1794-1796, 2005 | 589 | 2005 |
| Deposition of Alzheimer's β-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans S Vogelgesang, I Cascorbi, E Schroeder, J Pahnke, HK Kroemer, ... Pharmacogenetics and Genomics 12 (7), 535-541, 2002 | 441 | 2002 |
| Lethal recessive myelin toxicity of prion protein lacking its central domain F Baumann, M Tolnay, C Brabeck, J Pahnke, U Kloz, HH Niemann, ... The EMBO journal 26 (2), 538-547, 2007 | 284 | 2007 |
| An impaired neocortical Ih is associated with enhanced excitability and absence epilepsy U Strauss, MHP Kole, AU Bräuer, J Pahnke, R Bajorat, A Rolfs, R Nitsch, ... European Journal of Neuroscience 19 (11), 3048-3058, 2004 | 229 | 2004 |
| Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice M Krohn, C Lange, J Hofrichter, K Scheffler, J Stenzel, J Steffen, ... The Journal of clinical investigation 121 (10), 3924-3931, 2011 | 216 | 2011 |
| The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease S Vogelgesang, RW Warzok, I Cascorbi, C Kunert-Keil, E Schroeder, ... Current Alzheimer Research 1 (2), 121-125, 2004 | 204 | 2004 |
| The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease CM Lill, A Rengmark, L Pihlstrøm, I Fogh, A Shatunov, PM Sleiman, ... Alzheimer's & Dementia 11 (12), 1407-1416, 2015 | 176 | 2015 |
| Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia AI Korenkov, J Pahnke, K Frei, R Warzok, HWS Schroeder, R Frick, ... Neurosurgical review 23, 145-150, 2000 | 154 | 2000 |
| Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease H Hochstrasser, P Bauer, U Walter, S Behnke, J Spiegel, I Csoti, B Zeiler, ... Neurology 63 (10), 1912-1917, 2004 | 145 | 2004 |
| E2F1 in melanoma progression and metastasis V Alla, D Engelmann, A Niemetz, J Pahnke, A Schmidt, M Kunz, ... Journal of the National Cancer Institute 102 (2), 127-133, 2010 | 141 | 2010 |
| 2‐DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM) R Hoffrogge, S Mikkat, C Scharf, S Beyer, H Christoph, J Pahnke, E Mix, ... Proteomics 6 (6), 1833-1847, 2006 | 137 | 2006 |
| Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor … N Spaeth, MT Wyss, B Weber, S Scheidegger, A Lutz, J Verwey, ... Journal of Nuclear Medicine 45 (11), 1931-1938, 2004 | 136 | 2004 |
| DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling M Steder, V Alla, C Meier, A Spitschak, J Pahnke, K Fürst, BS Kowtharapu, ... Cancer cell 24 (4), 512-527, 2013 | 104 | 2013 |
| The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM SE Storck, AMS Hartz, J Bernard, A Wolf, A Kachlmeier, A Mahringer, ... Brain, behavior, and immunity 73, 21-33, 2018 | 103 | 2018 |
| Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice J Hofrichter, M Krohn, T Schumacher, C Lange, B Feistel, B Walbroel, ... Current Alzheimer Research 10 (10), 1057-1069, 2013 | 103 | 2013 |
| Overexpression of glial cell line-derived neurotrophic factor induces genes regulating migration and differentiation of neuronal progenitor cells J Pahnke, E Mix, R Knoblich, J Müller, M Zschiesche, B Schubert, ... Experimental cell research 297 (2), 484-494, 2004 | 101 | 2004 |
| The choroid plexus in health and in disease: dialogues into and out of the brain F Marques, JC Sousa, MA Brito, J Pahnke, C Santos, M Correia-Neves, ... Neurobiology of disease 107, 32-40, 2017 | 100 | 2017 |
| Alzheimer’s and ABC transporters—new opportunities for diagnostics and treatment J Pahnke, O Langer, M Krohn Neurobiology of disease 72, 54-60, 2014 | 99 | 2014 |
| Apolipoprotein E4 promotes the early deposition of Aβ42 and then Aβ40 in the elderly LC Walker, J Pahnke, M Madauss, S Vogelgesang, A Pahnke, EW Herbst, ... Acta neuropathologica 100, 36-42, 2000 | 97 | 2000 |
| Alzheimer's disease and blood–brain barrier function—Why have anti-β-amyloid therapies failed to prevent dementia progression? J Pahnke, LC Walker, K Scheffler, M Krohn Neuroscience & Biobehavioral Reviews 33 (7), 1099-1108, 2009 | 95 | 2009 |
Markus KrohnUniversity of Lübeck在 pharma.uni-luebeck.de 的电子邮件经过验证
